Seattle biotech company is the first to receive approval to test B cell gene therapy in humans Seattle biotech startup Immusoft has received approval to begin clinical trials of its novel strategy for treating genetic disease, the… Read More
Seattle gene therapy biotech startup Immusoft raises $4.5M Seattle-based biotech startup Immusoft raised another $4.5 million and landed a $467,000 NIH grant to help further development of its drugs… Read More
Seattle biotech startup raises $20M to develop gene therapy technology Seattle-based biotech startup Immusoft this week closed a $20 million Series B venture capital round that will fuel development of… Read More
Gene therapy startup Immusoft raises $3M, appoints new CEO as it approaches clinical trials Immusoft is looking to get its gene therapy technology into clinical trials, and the Seattle startup announced Friday that it… Read More
Gene therapy biotech startup Immusoft acquires Discovery Genomics Immusoft, a Seattle-based biotech startup that has developed a way to manipulate human immune cells, today announced the acquisition of… Read More
